-
221
Pharmacoeconomic analysis of flexible-dose administration regimen of Xeomine® in patients with focal dystonia
Published 2018-06-01“…Use of incobotulinumtoxin А in a flexible-dose regimen is pharmacoeconomically justied.…”
Get full text
Article -
222
Pharmacoeconomics and Utilization of Intravenous Proton Pump Inhibitors in a Tertiary Care Hospital
Published 2022-10-01Subjects: “…Pharmacoeconomics…”
Get full text
Article -
223
Pharmacoeconomic comparison of insulin glargine and insulin detemir in diabetes mellitus type 2
Published 2020-09-01“…Second generation insulin analogue — insulin glargine 300 UI/ml (GLA-300) — can provide an effective control of Diabetes Mellitus (DM) with minimal risk of hypoglycemic events and prevent of cardiovascular complications or events (CVS). Pharmacoeconomic comparison of most used insulins — GLA-300 and detemir (IDet) has been based on indirect treatment comparison in DM Type 2. …”
Get full text
Article -
224
Pharmacoeconomics of dapagliflozin in patients with type 2 diabetes mellitus with inadequate glycemic control
Published 2018-06-01“…The results are expressed in QALY and ICUR. Pharmacoeconomic analysis showed that the application of the strategy of treatment: metformin + dapagliflozin vs metformin + sitagliptin provided 9.83 and 9.82 QALYs respectively, and the ICUR — 341.413 rubles; metformin + dapagliflozin vs metformin + glimepiride provided 9.82 and 9.47 QALY respectively, and the ICUR — 145.213 rubles. …”
Get full text
Article -
225
-
226
PRELIMINARY RESULTS OF COMPARATIVE PHARMACOECONOMIC PROSPECTIVE STUDY OF DIFFERENT THERAPIES OF ARTERIAL HYPERTENSION
Published 2015-12-01“…To carry out a comparative pharmacoeconomic analysis of two different types of antihypertensive therapy in patients with arterial hypertension (HT). …”
Get full text
Article -
227
Evaluation of the pharmacoeconomics of drugs used for the treatment of long-term complications of sulfur mustard
Published 2016-08-01Subjects: Get full text
Article -
228
Pharmacoeconomic assessment of urinary tract infections in infants born to mather with pathological pregnancy
Published 2016-04-01Subjects: Get full text
Article -
229
PHARMACOECONOMIC JUSTIFICATION OF A WIDER USE OF PREVENTIVE HEMOPHILIA THERAPY IN THE RUSSIAN FEDERATION
Published 2018-02-01Subjects: Get full text
Article -
230
News from the Italian "Finanziaria 2008" and related pharmaceutical expenditure
Published 2008-03-01Subjects: “…pharmacoeconomics…”
Get full text
Article -
231
New rules for the generic drugs market introduced by the "Decreto Abruzzi"
Published 2009-03-01Subjects: “…pharmacoeconomics…”
Get full text
Article -
232
-
233
Theory and practice of the Health Technology Assessment in countries with a predominant public health service
Published 2009-06-01Subjects: “…pharmacoeconomics…”
Get full text
Article -
234
Equity of access to innovative drugs and sustainability of pharmaceutical expenditure
Published 2010-06-01Subjects: “…pharmacoeconomics…”
Get full text
Article -
235
-
236
Editorial: Big data shaping clinical trial landscape—Greater role for pharmacoeconomics in Asia
Published 2022-10-01Subjects: Get full text
Article -
237
A Pharmacoeconomic Comparison of Cost Variation among Hypolipidemic Drugs Available in Indian Market
Published 2021-12-01Get full text
Article -
238
PHARMACOECONOMIC STUDY OF OLMESARTAN/LERCANIDIPINE AND OFENOPRIL/LERCANIDIPINE COMBINATIONS IN THE TREATMENT OF PATIENTS WITH ESSENTIAL HYPERTENSION
Published 2017-03-01Subjects: “…pharmacoeconomic analysis…”
Get full text
Article -
239
Pharmacoeconomic research of surgical treatment of juvenile nasopharyngeal angiofibroma: preoperative endovascularly occlusion classes
Published 2020-10-01Subjects: “…pharmacoeconomic…”
Get full text
Article -
240
Comparative pharmacoeconomic analysis and qualitative evaluation methods of antibiotic prophylaxis during cataract surgery
Published 2018-05-01Subjects: Get full text
Article